Targeted Precision Therapy
Targeted Precision Therapy is a therapeutic approach that belongs to the class of clinical interventions designed for developmental encephalopathies and is distinguished by its reliance on molecular, genetic, or neurobiological biomarkers to guide the selection and application of individualized treatments aimed at specific pathological mechanisms.
61
Publications
3.3K
Citations
616
Authors
239
Institutions
Publications per year
2017–2026
54
61
A precision therapy against cancers driven by <i>KIT/PDGFRA</i> mutations
Erica Evans, Alexandra K. Gardino, Joseph L. Kim et al. · Science Translational Medicine · 2017 · 214 citations
Medicine, Oncology, Pharmacology +10
HER3 signaling and targeted therapy in cancer
Rosalin Mishra, Hima Patel, Samar Alanazi et al. · Oncology Reviews · 2018 · 183 citations · Full text
1–5 of 61
616
3
h-index
National Institute of Dental and Craniofacial Research, United States
3 publications · 214 citations
3
h-index
3
h-index
2
h-index
2
h-index
1–5 of 616
239

Chinese Academy of Sciences
Beijing, China
6 h-index
31 publications
1.4K citations
University of Chinese Academy of Sciences
Beijing, China
5 h-index
12 publications
650 citations
University of California San Diego
San Diego, United States
4 h-index
31 publications
2.1K citations
Oregon Health & Science University
Portland, United States
4 h-index
9 publications
482 citations

Thomas Jefferson University
Philadelphia, United States
3 h-index
12 publications
379 citations
Center for Cancer Research
Bethesda, United States
3 h-index
12 publications
1.1K citations

University of Colorado Denver
Denver, United States
3 h-index
3 publications
152 citations

Peking University
Beijing, China
3 h-index
6 publications
395 citations
1–8 of 239
3 publications · 253 citations
3
h-index
3 publications · 303 citations
3
h-index
2 publications · 56 citations
2
h-index
MCT · 2 publications · 186 citations
2
h-index
2 publications · 168 citations
2
h-index
1–5